187 related articles for article (PubMed ID: 36098807)
1. [Whole-body MRI in cancer predisposition syndromes].
Herrmann J; Esser M; Brecht I; Tsiflikas I; Schäfer JF
Radiologie (Heidelb); 2022 Dec; 62(12):1017-1025. PubMed ID: 36098807
[TBL] [Abstract][Full Text] [Related]
2. Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic.
Bojadzieva J; Amini B; Day SF; Jackson TL; Thomas PS; Willis BJ; Throckmorton WR; Daw NC; Bevers TB; Strong LC
Fam Cancer; 2018 Apr; 17(2):287-294. PubMed ID: 28988289
[TBL] [Abstract][Full Text] [Related]
3. Rates of Intervention and Cancer Detection on Initial versus Subsequent Whole-body MRI Screening in Li-Fraumeni Syndrome.
Kagami LAT; Du YK; Fernandes CJ; Le AN; Good M; Duvall MM; Baldino SE; Powers J; Zelley K; States LJ; Mathew MC; Katona BW; MacFarland SP; Maxwell KN
Cancer Prev Res (Phila); 2023 Sep; 16(9):507-512. PubMed ID: 37428016
[TBL] [Abstract][Full Text] [Related]
4. Whole-Body MRI Surveillance of Cancer Predisposition Syndromes: Current Best Practice Guidelines for Use, Performance, and Interpretation.
Grasparil AD; Gottumukkala RV; Greer MC; Gee MS
AJR Am J Roentgenol; 2020 Oct; 215(4):1002-1011. PubMed ID: 32809862
[No Abstract] [Full Text] [Related]
5. Whole-body magnetic resonance imaging of Li-Fraumeni syndrome patients: observations from a two rounds screening of Brazilian patients.
Paixão D; Guimarães MD; de Andrade KC; Nóbrega AF; Chojniak R; Achatz MI
Cancer Imaging; 2018 Aug; 18(1):27. PubMed ID: 30107858
[TBL] [Abstract][Full Text] [Related]
6. Current and Emerging Roles of Whole-Body MRI in Evaluation of Pediatric Cancer Patients.
Gottumukkala RV; Gee MS; Hampilos PJ; Greer MC
Radiographics; 2019; 39(2):516-534. PubMed ID: 30681900
[TBL] [Abstract][Full Text] [Related]
7. Li-Fraumeni Syndrome and Whole-Body MRI Screening: Screening Guidelines, Imaging Features, and Impact on Patient Management.
Consul N; Amini B; Ibarra-Rovira JJ; Blair KJ; Moseley TW; Taher A; Shah KB; Elsayes KM
AJR Am J Roentgenol; 2021 Jan; 216(1):252-263. PubMed ID: 33151095
[TBL] [Abstract][Full Text] [Related]
8. Whole-body magnetic resonance imaging of pediatric cancer predisposition syndromes: special considerations, challenges and perspective.
Saade-Lemus S; Degnan AJ; Acord MR; Srinivasan AS; Reid JR; Servaes SE; States LJ; Anupindi SA
Pediatr Radiol; 2019 Oct; 49(11):1506-1515. PubMed ID: 31620850
[TBL] [Abstract][Full Text] [Related]
9. Whole-body magnetic resonance imaging (WB-MRI) in oncology: recommendations and key uses.
Petralia G; Padhani AR; Pricolo P; Zugni F; Martinetti M; Summers PE; Grazioli L; Colagrande S; Giovagnoni A; Bellomi M;
Radiol Med; 2019 Mar; 124(3):218-233. PubMed ID: 30430385
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of imaging approaches for early tumor detection in children with Li-Fraumeni syndrome.
Tewattanarat N; Junhasavasdikul T; Panwar S; Joshi SD; Abadeh A; Greer MLC; Goldenberg A; Zheng G; Villani A; Malkin D; Doria AS
Pediatr Radiol; 2022 Jun; 52(7):1283-1295. PubMed ID: 35391548
[TBL] [Abstract][Full Text] [Related]
11. Clinical Applications and Controversies of Whole-Body MRI:
Ahlawat S; Debs P; Amini B; Lecouvet FE; Omoumi P; Wessell DE
AJR Am J Roentgenol; 2023 Apr; 220(4):463-475. PubMed ID: 36169545
[TBL] [Abstract][Full Text] [Related]
12. Screening with whole-body magnetic resonance imaging in pediatric subjects with Li-Fraumeni syndrome: A single institution pilot study.
O'Neill AF; Voss SD; Jagannathan JP; Kamihara J; Nibecker C; Itriago-Araujo E; Masciari S; Parker E; Barreto M; London WB; Garber JE; Diller L
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 29077256
[TBL] [Abstract][Full Text] [Related]
13. Imaging of cancer predisposition syndromes.
Greer MC
Pediatr Radiol; 2018 Aug; 48(9):1364-1375. PubMed ID: 30078044
[TBL] [Abstract][Full Text] [Related]
14. [Imaging of tumor predisposition syndromes].
Glutig K; Pfeil A; Renz DM
Radiologe; 2021 Jul; 61(7):658-666. PubMed ID: 34170362
[TBL] [Abstract][Full Text] [Related]
15. Whole-Body MRI Screening in Children With Li-Fraumeni and Other Cancer Predisposition Syndromes.
Benusiglio PR; Brugières L; Caron O
AJR Am J Roentgenol; 2016 Mar; 206(3):W52. PubMed ID: 26901030
[No Abstract] [Full Text] [Related]
16. Reply to "Whole-Body MRI Screening in Children With Li-Fraumeni and Other Cancer-Predisposition Syndromes.".
Anupindi SA; Chauvin NA; Nichols KE
AJR Am J Roentgenol; 2016 Mar; 206(3):W53. PubMed ID: 26901031
[No Abstract] [Full Text] [Related]
17. Whole-body MRI in oncology: A comprehensive review.
Vulasala SS; Virarkar M; Karbasian N; Calimano-Ramirez LF; Daoud T; Amini B; Bhosale P; Javadi S
Clin Imaging; 2024 Apr; 108():110099. PubMed ID: 38401295
[TBL] [Abstract][Full Text] [Related]
18. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Cancer at Baseline Screening in the National Cancer Institute Li-Fraumeni Syndrome Cohort.
Mai PL; Khincha PP; Loud JT; DeCastro RM; Bremer RC; Peters JA; Liu CY; Bluemke DA; Malayeri AA; Savage SA
JAMA Oncol; 2017 Dec; 3(12):1640-1645. PubMed ID: 28772286
[TBL] [Abstract][Full Text] [Related]
20. Whole-body MRI for the staging and follow-up of patients with metastasis.
Schmidt GP; Reiser MF; Baur-Melnyk A
Eur J Radiol; 2009 Jun; 70(3):393-400. PubMed ID: 19457631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
